ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 55 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q2 2021. The put-call ratio across all filers is 1.54 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $28,000 | -73.8% | 28,489 | -70.8% | 0.00% | -66.7% |
Q2 2021 | $107,000 | +2575.0% | 97,590 | +1674.4% | 0.00% | – |
Q3 2020 | $4,000 | -98.8% | 5,500 | -89.8% | 0.00% | -100.0% |
Q1 2014 | $343,000 | +19.1% | 54,000 | +20.0% | 0.05% | -4.2% |
Q4 2013 | $288,000 | – | 45,000 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
A.R.T. Advisors, LLC | 20,419 | $16,000 | 0.09% |
Maven Securities LTD | 1,000,000 | $795,000 | 0.07% |
Verdence Capital Advisors LLC | 88,382 | $69,000 | 0.02% |
Hayden Royal, LLC | 26,000 | $20,000 | 0.01% |
GSA CAPITAL PARTNERS LLP | 55,752 | $44,000 | 0.01% |
Qube Research & Technologies Ltd | 519,063 | $407,000 | 0.01% |
Virtu Financial LLC | 39,683 | $31,000 | 0.01% |
Global Strategic Investment Solutions, LLC | 23,000 | $18,000 | 0.01% |
Jacobi Capital Management LLC | 25,000 | $20,000 | 0.00% |
RVW Wealth, LLC | 19,000 | $15,000 | 0.00% |